Corrigendum: A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: The European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS) [Annals of Oncology 2015; 26: 1547�1573 (doi: 10.1093/annonc/mdv249]

N. I. Cherny, R. Sullivan, U. Dafni, J. M. Kerst, A. Sobrero, C. Zielinski, E. G.E. de Vries, M. J. Piccart

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish
Pages (from-to)2901-2905
Number of pages5
JournalAnnals of Oncology
Issue number11
Publication statusPublished - Jan 1 2017

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this